{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:20:39Z","timestamp":1791778839155,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4181,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/modpathol.2011.57","type":"journal-article","created":{"date-parts":[[2011,4,8]],"date-time":"2011-04-08T15:54:12Z","timestamp":1302278052000},"page":"1031-1035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["KIT mutations in ocular melanoma: frequency and anatomic distribution"],"prefix":"10.1016","volume":"24","author":[{"given":"Michelle L","family":"Wallander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester J","family":"Layfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyska L","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Mamalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl R","family":"Tripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A","family":"Holden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2011.57_bib1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/sj.jid.5700125","article-title":"Distinctive role of the ckit receptor tyrosine kinase signaling in mammalian melanocytes","volume":"126","author":"Alexeev","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2011.57_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.jid.5700164","article-title":"Kit and melanocyte migration","volume":"126","author":"Grichnik","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2011.57_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1523-1747.1998.00272.x","article-title":"The scf\/kit pathway plays a critical role in the control of normal human melanocyte homeostasis","volume":"111","author":"Grichnik","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2011.57_bib4","first-page":"939","article-title":"Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression","volume":"10","author":"Montone","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2011.57_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ijc.2910520207","article-title":"Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor","volume":"52","author":"Natali","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2011.57_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.humpath.2005.03.015","article-title":"Human malignant melanoma: detection of braf- and c-kit-activating mutations by high-resolution amplicon melting analysis","volume":"36","author":"Willmore-Payne","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2011.57_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.22681","article-title":"L576p kit mutation in anal melanomas correlates with kit protein expression and is sensitive to specific kinase inhibition","volume":"121","author":"Antonescu","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2011.57_bib8","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"Kit gene mutations and copy number in melanoma subtypes","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2011.57_bib9","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of kit in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2011.57_bib10","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2007.14.0707","article-title":"Major response to imatinib mesylate in kit-mutated melanoma","volume":"26","author":"Hodi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2011.57_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.bjc.6604482","article-title":"Phase ii trial of imatinib mesylate in patients with metastatic melanoma","volume":"99","author":"Kim","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2011.57_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1755-148X.2008.00475.x","article-title":"Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a k642e kit mutation","volume":"21","author":"Lutzky","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/modpathol.2011.57_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ncponc1251","article-title":"Complete response of stage iv anal mucosal melanoma expressing kit val560asp to the multikinase inhibitor sorafenib","volume":"5","author":"Quintas-Cardama","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1038\/modpathol.2011.57_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yexmp.2008.03.010","article-title":"Tyrosine kinase activating mutations in human malignancies: implications for diagnostic pathology","volume":"85","author":"Holden","year":"2008","journal-title":"Exp Mol Pathol"},{"key":"10.1038\/modpathol.2011.57_bib15","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/modpathol.2009.116","article-title":"Correlation between kit expression and kit mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous\/mucosal type","volume":"22","author":"Torres-Cabala","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2011.57_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/jid.2009.334","article-title":"Kit as a therapeutic target in melanoma","volume":"130","author":"Garrido","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2011.57_bib17","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1167\/iovs.03-1196","article-title":"C-kit-dependent growth of uveal melanoma cells: a potential therapeutic target?","volume":"45","author":"All-Ericsson","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/modpathol.2011.57_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1078-0432.CCR-08-2243","article-title":"Overexpression of the kit\/scf in uveal melanoma does not translate into clinical efficacy of imatinib mesylate","volume":"15","author":"Hofmann","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2011.57_bib19","doi-asserted-by":"crossref","first-page":"31769","DOI":"10.1074\/jbc.M403907200","article-title":"Roles of stem cell factor\/c-kit and effects of glivec\/sti571 in human uveal melanoma cell tumorigenesis","volume":"279","author":"Lefevre","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.2011.57_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00008390-200304000-00008","article-title":"Expression of the c-kit receptor in choroidal melanomas","volume":"13","author":"Mouriaux","year":"2003","journal-title":"Melanoma Res"},{"key":"10.1038\/modpathol.2011.57_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00428-003-0883-2","article-title":"Sequence analysis and high-throughput immunohistochemical profiling of kit (cd 117) expression in uveal melanoma using tissue microarrays","volume":"443","author":"Pache","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2011.57_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-3163-4-19","article-title":"The role of c-kit and imatinib mesylate in uveal melanoma","volume":"4","author":"Pereira","year":"2005","journal-title":"J Carcinog"},{"key":"10.1038\/modpathol.2011.57_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/PAI.0b013e3181ec4f95","article-title":"C-kit and pdgfra zygosity in gastrointestinal stromal tumors: correlation with tumor site, tumor size, exon, and cd117 immunohistochemistry","volume":"19","author":"Wallander","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1038\/modpathol.2011.57_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10637-008-9143-2","article-title":"O-mel-inib: a cancero-pole nord-ouest multicenter phase ii trial of high-dose imatinib mesylate in metastatic uveal melanoma","volume":"26","author":"Penel","year":"2008","journal-title":"Invest New Drugs"},{"key":"10.1038\/modpathol.2011.57_bib25","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.humpath.2006.01.003","article-title":"Braf and c-kit gene copy number in mutation-positive malignant melanoma","volume":"37","author":"Willmore-Payne","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2011.57_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10147-010-0087-0","article-title":"Low incidence of kit gene mutations and no pdgfra gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases","volume":"15","author":"Terada","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1038\/modpathol.2011.57_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.jid.5701036","article-title":"Absence of pdgfra mutations in primary melanoma","volume":"128","author":"Curtin","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2011.57_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-007-0524-2","article-title":"C-kit protein expression correlated with activating mutations in kit gene in oral mucosal melanoma","volume":"452","author":"Rivera","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2011.57_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/hupa.2002.124124","article-title":"Biology and genetic aspects of gastrointestinal stromal tumors: kit activation and cytogenetic alterations","volume":"33","author":"Heinrich","year":"2002","journal-title":"Hum Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201157","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222028241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222028241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:04:04Z","timestamp":1760231044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222028241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0893395222028241"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2011.57","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KIT mutations in ocular melanoma: frequency and anatomic distribution","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2011.57","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}